We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current OMGA market cap is 7.9M. The company's latest EPS is USD -1.7597 and P/E is -0.08.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 831k | 989k | 2.36M | 2.13M | 2.61M |
| Operating Income | -22.9M | -20.88M | -20.45M | -16.58M | -16.42M |
| Net Income | -22.25M | -20.21M | -20.13M | -16.31M | -16.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 144k | 2.07M | 3.09M |
| Operating Income | -17.34M | -28.65M | -66.03M | -102.77M | -100.26M |
| Net Income | -17.95M | -29.45M | -68.28M | -102.7M | -97.43M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 217.81M | 204.37M | 183.68M | 168.23M | 152.73M |
| Total Liabilities | 141.77M | 146.35M | 142.33M | 141.96M | 141.18M |
| Total Equity | 76.04M | 58.02M | 41.35M | 26.26M | 11.54M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.12M | 28.08M | 233.33M | 146M | 204.37M |
| Total Liabilities | 15.33M | 17.49M | 32.71M | 40.03M | 146.35M |
| Total Equity | -35.92M | -64.63M | 200.63M | 105.97M | 58.02M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -74.42M | -91.51M | -11.81M | -24.48M | -38.49M |
| Investing | 45.38M | 47.52M | 4.47M | 4.07M | 4.05M |
| Financing | 40.2M | 41.82M | -1.07M | -2.18M | -3.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.68M | -26.13M | -57.61M | -98.52M | -91.51M |
| Investing | -885k | -1.81M | -40.4M | -18.06M | 47.52M |
| Financing | 11.99M | 48.62M | 261.54M | 708k | 41.82M |
| Market Cap | 7.9M |
| Price to Earnings Ratio | -0.08 |
| Price to Sales Ratio | 2.5 |
| Price to Cash Ratio | 0.11 |
| Price to Book Ratio | 0.13 |
| Dividend Yield | - |
| Shares Outstanding | 55.37M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -92.80% |
| 52 Week High | 2.14 |
| 52 Week Low | 0.0953 |
| Spread (Intraday) | 0 (4.06%) |
| Company Name | Omega Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.omegatherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
